Category: Kinetic Concepts Inc.
Kinetic Concepts Inc. wins FDA clearance for its next-generation negative-pressure wound therapy device, the V.A.C.Via.
Kinetic Concepts Inc. said it won 510(k) clearance from the FDA for a new negative-pressure wound therapy device, the V.A.C.Via, saying it plans to have it on the market in early December.
The V.A.C.Via is a portable wound care system featuring a diaphragm pump for faster draw down, longer battery life and a higher leak rate threshold, according to a press release.
Q3 revenues dip for Kinetic Concepts and losses loom for its newly formed threesome with Systagenix and LifeCell Corp.
Sales took a minor hit for Kinetic Concepts during its 3rd quarter 2013, reporting as part of the Centaur Guernsey companies which now includes both LifeCell and Systagenix.
Orthofix chairman Jim Gero steps down and is replaced by private equity player Randy Thurman.
Orthofix (NSDQ:OFIX) chairman Jim Gero stepped down, effective immediately, to be replaced by Randy Thurman.
Gero, a member of the orthopedic medical device company's board since 1998, was named chairman in 2005. He'll continue as a consultant to the board until 2015, according to a press release.
Kinetic Concepts Inc. closes its $485 million buyout of wound care company Systagenix.
Kinetic Concepts Inc. said it's closed the $485 million buyout of fellow privately owned wound-care company Systagenix, which it plans to unite with its LifeCell regenerative therapies unit.
Noble Biomaterials renews its deal with Kinetic Concepts Inc. Manufacturing for KCI's V.A.C. GranuFoam silver dressing.
Noble Biomaterials, a bacterial management company, said it renewed its partnership with KCI Manufacturing, an affiliate of Kinetic Concepts Inc., for its V.A.C. GranuFoam silver dressing.
Kinetic Concepts, LifeCell Corp. and Systagenix plan to join forces to form a single wound care, biologics and regenerative medicines giant under Kinetic Concepts president & CEO Joe Woody.
Just weeks after the $485 million merger of Kinetic Concepts and Systagenix, the duo plans to merge forces with LifeCell Corp., forming a 3-headed hydra of wound care, biologics and regenerative therapies.
The new company will be run by KCI president & CEO Joe Woody, with LifeCell commercial operations chief Phil Croxford as senior vice president and "permanent leader" of LifeCell, according to a joint statement.